Additionally, the infiltration of M1-polarized tumor-associated macrophages (TAMs - F4/80+, p-Stat1 (Y701)+) was increased in the combination therapy group, which is often correlated with improved survival and outcome in breast cancer patients (Fig. 7g) 65–67. Here, STAT1 is linked to breast cancer.